Joshua Cohen is a Boston-based writer who covers health policy. Two weeks ago, the Food and Drug Administration approved Xolair (omalizumab) for immunoglobulin E-mediated food allergy in certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback